Healthtech Startups

Diamond Therapeutics is a preclinical biotechnology company developing drug treatments for psychiatric and neurological disorders, with a focus on the pharmacology and therapeutic use of psychedelic compounds. It brings together clinical researchers and pharmaceutical development experts to advance early-stage candidates for mood and related disorders.

3 investors

Diana Health provides personalized women's healthcare through collaborative teams of OB/GYNs, midwives, mental health therapists, dietitians, and wellness coaches. The company offers comprehensive whole-health care for women across reproductive, mental, and nutritional domains with emphasis on patient autonomy and compassionate delivery.

3 investors

A pharmaceutical company developing treatments for serious chronic diseases with a focus on long-term health solutions and improving medicine access and affordability globally. The company conducts research and development, collaborates with scientists and biotech innovators, and has reached millions of patients through its innovative therapeutic approaches.

3 investors

Dieta is a digestive health company that uses data to provide personalized management for people with IBS (irritable bowel syndrome). The team includes data scientists, doctors, dietitians, and engineers focused on digestive health.

3 investors

DifferentKind provides a patient-experience intelligence platform for dental support organizations (DSOs), dentists, and dental insurers, capturing verified patient experience data through live dashboards, PMS integrations, and AI analysis. It helps dental organizations improve operations, patient and employee retention, case acceptance, and network quality, with benchmarking and reputation tools.

3 investors

Difinity develops medical devices and technologies focused on emergency medication delivery and needle safety. The company is engineering an automatic injection device with interchangeable pods for use in emergency medical situations, and a safer hypodermic needle delivery system called NeedSafe.

3 investors

DigiMe3D provides 3D body-scanning and analysis tools used to track physical changes in clients, serving dietitians, gyms, personal trainers, physiotherapists, and sports clubs. Its products support nutrition, fitness, and clinical body-posture analysis workflows.

3 investors

Digistain develops imaging technology to grade breast cancer biopsies and assess cancer recurrence risk faster and more cost-effectively than traditional methods. The company serves breast oncologists and pathologists in clinical and diagnostic settings.

3 investors

DiogenX is a preclinical-stage biotech company developing biologic therapeutics aimed at restoring insulin-producing beta cells for people with Type 1 diabetes. It focuses on new treatment options for diabetic patients as an alternative to lifelong exogenous insulin.

3 investors

Ditto Bio uses AI to identify protein candidates from parasites and pathogens for treating autoimmune diseases. The company mines natural compounds from viruses, ticks, and worms whose immune-modulating properties have evolved over millions of years.

3 investors

3 investors

Docbot developed AI-powered software for gastroenterology, using computer vision to detect polyps and assist diagnosis during endoscopy and colonoscopy procedures.

3 investors

DocGo provides mobile and virtual health services, including medical transportation for hospitals, care gap closure and longitudinal care programs for payers, and population health programs for public health departments. It operates across all 50 US states and the United Kingdom, serving hospitals, health payers, and public health organizations.

3 investors

Doctible is a patient engagement and practice growth platform that helps healthcare practices manage appointment booking, patient communication, online reputation, and websites. Founded in 2014, it serves dental, vision, and chiropractic professionals across the United States.

3 investors

Dorian Therapeutics was a biotechnology startup developing senoblockers, drugs designed to rejuvenate cells and tissues by targeting aging-related mechanisms. Acquired by Altos Labs.

3 investors

Dorsata builds clinical workflow software for healthcare providers, delivering point-of-care tools and content (including ACOG guidelines) that translate provider best-practices into structured workflows. The company serves medical practices and clinicians as a SaaS platform for improving care quality and workflow efficiency.

3 investors

Dot Glasses provides mobile optical shops—portable kits with assembly and testing equipment—enabling rapid eye care delivery and custom glasses manufacturing in underserved communities. The company addresses the gap in vision care access, with products ranging from small lightweight kits serving 20 people to larger kits accommodating 120.

3 investors

Dot Health provides a platform for patients to access, track, and share their health records and medical data with their healthcare providers. The company serves patients and healthcare systems in Canada, addressing the fragmented and paper-based nature of medical record sharing.

3 investors

Doximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.

3 investors

Dr. SAM is a veterinary practice offering modern animal health services with a focus on preventive care, digestive health, and animal welfare in Germany. The practice combines conventional veterinary medicine with traditional approaches and emphasizes compassionate care for companion animals.

3 investors

Dracen Pharmaceuticals is a private drug developer working at the intersection of cancer metabolism and immuno-oncology, developing glutamine antagonists that inhibit tumor glutamine metabolism and remodel the tumor microenvironment. Its lead candidate, sirpiglenastat (DRP-104), is in clinical trials for advanced solid tumors including KEAP1/NFE2L2-altered non-small cell lung cancer.

3 investors

Droplet Biosciences develops cancer diagnostics with a focus on liquid biopsy and precision oncology. The company works in the molecular diagnostics space for cancer detection and personalized medicine.

3 investors

The page presented is corporate content for Novartis, a pharmaceutical company that develops medicines across areas such as multiple sclerosis, cardiovascular disease, and oncology. The content covers clinical trial results, financial results, and annual reporting rather than the expected dtxpharma.com company.

3 investors

Durcal addresses care and support challenges for elderly populations, particularly in Spain where aging demographics create growing demand for services addressing loneliness, fall prevention, and autonomy loss.

3 investors